The choice of outcomes in systematic reviews of the effects of interventions is crucial, dictating which data are included and analyzed. Full prespecification of outcomes in systematic reviews can reduce the risk of outcome reporting bias but, this issue has not been widely investigated. This study is the first to analyze the nature and specification of outcomes used in Cochrane Wounds (CW) systematic reviews. Adequacy of outcome specification was assessed using a five-element framework of key outcome components: outcome domain, specific measurement, specific metric, method of aggregation, and time points. We identified all CW review titles associated with a protocol published on or before October 1, 2014. We categorized all reported outcome domains and recorded whether they were primary or secondary outcomes. We explored outcome specification for outcome domains reported in 25% or more of the eligible protocols. We included 106 protocols and 126 outcome domains; 24.6% (31/126) domains were used as primary outcomes at least once. Eight domains were reported in 25% of protocols: wound healing, quality of life, costs, adverse events, resource use, pain, wound infection, and mortality. Wound healing was the most completely specified outcome domain (median 3; interquartile range [IQR] 51-5) along with resource use (median 3; IQR 2-4). Quality of life (median 1; IQR 1-3), pain (median 1; IQR 1-3), and costs (median 1; IQR 1-4) were the least completely specified outcome domains. Outcomes are frequently poorly prespecified and the elements of metric, aggregation, and time-point are rarely adequately specified. We strongly recommend that reviewers be more vigilant about prespecifying outcomes, using the five-element framework. Better prespecification is likely to improve review quality by reducing bias in data abstraction and analysis, and by reducing subjectivity in the decision of which outcomes to extract; it may also improve outcome specification in clinical trial design and reporting.
Over recent years, there has been increased focus on the choice of outcomes for measurement in randomized controlled trials (RCTs) and systematic reviews, and how and why these choices are made. In clinical trials, an outcome is an event or measure in study participants that is used to assess the effectiveness and/or safety of the intervention being studied, or sometimes adverse events. 1 There are two main types of outcomes: dichotomous and continuous. Examples of dichotomous outcomes related to wound care include: death; wound healing and wound infection. Examples of continuous outcomes include: percentage reduction in wound area from baseline 2 ; health-related quality of life; activity levels; weight and blood pressure. 3 Researchers conducting trials and reviews generally select, a priori, at least one primary outcome and a number of secondary outcomes. The term "prespecification" refers to the process whereby decisions that could be subject to bias are made at the protocol stage, BEFORE any data have been collected. This avoids decisions (such as which is the most important outcome) being influenced by knowledge of the results. 4 The primary outcome(s) should be the most clinically relevant and important to patients and policy makers and, in the case of RCTs, is/are used as the basis for the calculation of the sample size and/or power. Secondary outcomes should also be important for decision making, but are less critical than the primary outcome. 3, 5, 6 Once specified, primary outcomes generally are the key study findings. This commitment to reporting the primary outcome is one element of avoiding outcome reporting bias resulting from the selective reporting of outcomes based on their results (e.g., statistical significance) rather than a priori specification. 7 This bias has been reported as a problem in RCTs 8 as well as in systematic reviews. 5, 6 A related issue to reporting biases is that of "spin," in which outcomes that are not associated with a treatment effect are de-emphasized in reports and outcomes with statistically significant findings are made more prominent. Where RCTs do not find a statistically significant treatment effect for the primary outcome, reports often promote the importance of statistically significant effects on secondary outcomes, especially in Abstract and Conclusion sections. 9, 10 Outcome prespecification is particularly important for systematic reviews, which gather data from multiple RCTs, each of which might measure a given outcome in a number of different ways. As an example, a systematic review might plan to include data on quality of life. However, this outcome can be measured using various instruments and at multiple time points. Without further specification of the outcome at the outset, there is a risk that systematic review authors would make post hoc decisions about which trials and outcomes provide acceptable measures of quality of life. Consequently, there may be a conscious or subconscious focus on those results that seem to demonstrate differences between treatment groups, rather than those that were considered the most relevant a priori.
Prior research has elucidated a five-element framework of key components that should be considered during prespecification of outcomes in systematic reviews and RCTs. 11, 12 Saldanha et al. 11 modified the list initially proposed by Zarin et al. 12 by introducing time point as a standalone element whereas this was previously integrated into the four other elements. The five-element framework includes:
(1) Domain or outcome title; (2) Specific measurement or technique/instrument used to make the measurement; (3) Specific metric or format of the outcome data from each participant that will be used for analysis; (4) Method of aggregation or how data from each group will be summarized; and (5) Time points that will be used for analysis. Thus, a fully specified outcome has the five elements used by Saldanha et al.
11 (Table 1) .
Cochrane systematic reviews are an important resource for health care professionals, patients, and policy makers. Data show that systematic reviews produced by Cochrane Wounds (CW) are among the most highly accessed systematic reviews in the Cochrane Library. 13 CW reviews cover all aspects of treatment and prevention of wounds and healthcare-acquired infections including surgical site infections. There is a range of possible outcomes that can be analyzed in wounds-related reviews; it is important to further understand which are most commonly used, which are most frequently specified as primary outcomes, and how well outcomes are prespecified in CW protocols. This is a particularly pertinent issue in wound care as there are currently no core outcome sets. A core outcome set is minimum set of outcomes that should be measured and reported from clinical trials on a given topic.
14 They have been proposed as one mechanism to improve the consistency of outcome measurement and reporting in RCTs and systematic reviews. 3, 15, 16 As with the previous study of outcome specification, 11 our aim was to explore, describe, and understand how outcomes have been conceptualized in systematic reviews. The current study focuses specifically on CW reviews. We assessed the completeness of outcome prespecification, by exploring the use of the five elements: domain, specific measurement, specific metric, method of aggregation, and time points. The insights gained will inform future discussions about how outcomes can be optimally specified for both future reviews and future RCTs in the field of wound care.
METHODS

Source of data
We identified all CW review titles associated with a protocol published on or before October 1, 2014. For these titles, we located the oldest published version of the protocol available. Where a published protocol was not available in the Cochrane Library, we requested access from the CW Managing Editor. Where a published version of a protocol was still not available, we used the Methods section of the most recent published review in lieu of the protocol. We extracted the following data for included protocols: year of publication and wound type. How we judged and classified the specifications of outcomes based on individual RCTs
Extraction of outcome domains
One author (ZL) extracted a list of all outcome domains from the Methods section of eligible CW protocols (and reviews where protocols were not available-for ease, all texts will be referred to as protocols from now on). The definition and grouping of domains was then verified by a second author (JD) with input from a third author (NC or IS) where required. For example: the outcomes "length of hospital stay," "number of dressing change," and "staff time" were initially listed as three different domains by one author (ZL); then after checking by other authors (JD and NC), these outcomes were grouped under the domain of "resource use." Additionally, we recorded whether each outcome was classed as primary or secondary in the protocol; where this was not specified we recorded them as secondary outcomes. We extracted data on further outcome specification for domains that appeared in at least 25% of included protocols. For each outcome domain (element 1), we extracted the named specific measurement(s) (element 2) and method(s) of aggregation (element 4), and whether or not a specific metric (element 3) and time point (element 5) were specified in the protocol. We anticipated that some outcome domains could have multiple specific measurements/ specific metrics/methods of aggregation/time points in a single protocol. For example, the domain of wound healing could be associated with the specific measurements of "proportion of participants with a completely healed wound" and "change in wound area." In other words, one domain could have multiple outcome specifications. When this was the case, we looked for (and extracted) the specific measurements, specific metrics, methods of aggregation, and time points for each outcome specification. Detailed below are our processes for data extraction for elements 2-5 for each outcome domain.
Data extraction on outcome specification: specific measurement(s)
We considered a specific measurement as specified if the review authors stated how the outcome should be measured, including (where relevant) with which instruments, tools, scales, scores, and/or how the outcome should be defined. We assessed whether the measurement had been specified, and we extracted the detail of the measurement(s). If methods of measurement were not prespecified, or relevant phenomena not defined (e.g., if "wound healing" was not defined), we classified the specific measurement as "unspecified" (see Table 2 ).
Specific metric(s)
We considered a specific metric as specified if the review authors specified how they would analyze the data, including change from baseline, value at a time point, or timeto-event. We classified the specific metric as specified or not, and noted the type of specific metric (see Table 2 ).
Method of aggregation
We considered method of aggregation to have been specified if the review authors specified how the data were to be summarized, including as mean, median, percentage or proportion, or an absolute number. Where review authors did not mention any method of aggregation, we classified it as unclear (see Table 2 ).
Time point(s)
We noted whether the authors specified the time points to be used in their analysis. Where authors stated that this would be the "latest time point in the trial" or similar we regarded this as specified, even if one such statement was made for all outcomes in the review. The example of "time to complete healing" was classified as "time point specified" because time is intrinsic to the metric (i.e., time-to-event) (see Table 2 ).
After initial pilot testing of our data abstraction process using 10 protocols, one investigator (ZL) extracted data for all protocols into a Microsoft Excel spreadsheet. A second investigator (JD) verified all extracted data. In order to check agreement, a third investigator (IS) and a fourth investigator (NC) independently extracted data from 10 randomly selected protocols. All discrepancies were resolved through discussion.
Analysis
We present a descriptive analysis of the number, types, and degree of specification of outcomes in the included protocols. The extent of completeness of outcome specification was assessed based on the use of the five possible elements for each main outcome domain. If all the five elements were identified for one outcome, then we labeled it as a "completely specified outcome." We summarize the median and interquartile range (IQR) for the number of outcome elements (out of a total of five) specified for each included outcome domain and then describe the elements in more detail for each domain. We also report the frequency of categories of specific metric, method of aggregation, and time points for each outcome domain.
RESULTS
Characteristics of protocols examined and outcome domains used
We identified 106 published systematic reviews published by CW (Appendix 1). We obtained the original protocols for 91 of the 106 titles (86%). We used the Methods section of current reviews for the remaining 15 titles (14%). Of the 91 protocols, 85 (93%) were associated with a published completed review. Appendix 2 provides full data extraction of the number of times each outcome domain was used.
Interventions to prevent and/or treat wound infection was the most frequently addressed topic in the 106 protocols (25%), followed by venous leg ulcer treatments (14%), surgical wound treatments (13%), pressure ulcer treatments (11%), and foot ulcer treatments (10%). This classification was based on the system used by CW. Most of the included reviews (95/106; 90%) were published after the year 2000 (Table 3) .
We identified 126 unique outcome domains (Appendix 2); these were used 655 times across the 106 protocols. Of the 126 outcome domains, 31 (25%) were listed as primary outcomes at least once. Table 4 provides the 10 most frequently used outcome domains.
Most frequent outcomes
For further analysis, we focused on the eight outcome domains that were each included in at least 25% of protocols, i.e., wound healing, adverse events, wound infection, quality of life, cost, resource use, pain, and mortality (Table 5) . At least one of these eight domains was included in 101/106 (95%) protocols. Across the 101 reviews, these eight domains were used a total of 494 times. The most frequent domains were wound healing (59/101; 58%), quality of life (56/101; 55%), and costs (56/101; 55%) ( Table 3 ). The wound healing domain (with its associated specific measurements of time to healing, proportion of wounds healed at a certain time point, and change in wound size) was the most frequent domain (101 protocols-presenting 170 usages, of which 127 usages were identified as primary outcomes). The domain "costs" was also frequently used (60 instances), but never as a primary outcome (Table 5 ).
Number of completely specified elements
Each outcome specification was considered by default to have specified a minimum of one element (i.e., outcome domain). We assessed how frequently the remaining four possible elements (specific measurement, specific metric, method of aggregation and time points) were specified for each of the eight outcome domains. Overall, a median of two elements was specified per outcome domain. Wound healing was the most completely specified outcome domain (median three elements; IQR 1-5) (Figure 1 ). The domain of wound healing was completely specified once. 122 Resource use was specified for a median of three elements (IQR 2-4) (Figure 1 ). The most incompletely specified outcome domains were quality of life (median 1; IQR 1-3), pain (median 1; IQR 1-3), and costs (median 1; IQR 1-4). Table 2 provides some examples of outcome text and their extent of complete and incomplete specifications. Table 6 gives more detail regarding the distribution of specific measurements (element 2), specific metrics (element 3), methods of aggregation (element 4), and time points (element 5) across outcome domains. The patterns of completeness for individual elements were similar across the eight outcome domains. Specific metrics and methods of aggregation were specified least often, while domains and time points were specified more often than other elements. For example, the specific measurements for the domains of resource use and mortality were specified 98-100% of the time. In contrast, the domain of wound healing, a key outcome in wounds research, was associated with the most poorly specified specific measurement (12%), usually because what constituted wound healing had not been prespecified. The specific metrics for the domains of adverse events, cost, mortality, pain, and quality of life were also poorly specified. Method of aggregation was the most poorly specified element (76-100% unclear), and when specified, it was usually a "percentage/proportion." Similarly, time points were very poorly specified, except for the domain of wound healing.
Comparability of specification across domains
DISCUSSION
To the best of our knowledge, this is the first investigation of the nature and adequacy of specification of outcomes in systematic reviews of wounds research. The large volume of possible outcomes that can be measured and reported in wounds research makes this a particularly important area to explore.
Overview of outcome domains
We identified 126 different outcome domains specified across 106 systematic review protocols published by CW. This large number of outcome domains partly reflects the wide range of target conditions covered by the scope of this Cochrane Wounds (a Cochrane Review Group that encompasses healthcare-acquired infections as well as wounds), but also reflects variation in outcome selection and/or reporting. We identified the most frequent eight outcome domains that were included in 25% or more of the included protocols, leaving the majority of outcome domains (n 5 118) being used relatively infrequently. While complete wound healing has been recommended as the most important clinically relevant outcome in many cases, there frequently is focus on the surrogate or interim outcome of changes in wound size. 123, 124 Other important outcomes include wound infection, which can be captured in several different ways, such as pain and quality of life. 123, 125 Outcome specification
In our study sample, specific measurement was the element most often specified among the five elements of a well-specified outcome, while method of aggregation and time points of interest were the least often specified. For example, review authors often stated "wound healing" but did not specify how data would be aggregated or the time point at which they were interested in the outcome. Notably, timing is crucial in the assessment of wound healing. When outcome time points of interest are not prespecified in a systematic review, it is not obvious how data from studies with different follow-up periods would be dealt with. Wound healing outcomes measured at 4 and 52 weeks are very different, and since healing is unlikely to be a linear process combining data from different time points is likely inappropriate. Additionally, there is the issue of increased risk of type 1 errors when outcomes measured at multiple time points are all analyzed separately. This issue needs to be considered in more detail at the outset of a systematic review. 123 This is an important issue that likely requires more attention in reviews due to its importance not only from the clinical perspective but also with regard to resource use and economic cost. 123 Primary outcomes tended to be more completely specified than secondary outcomes. Wound healing was the most frequent primary outcome and the most well specified outcome domain with four or more elements specified in 19% of cases. This finding echoed that of Saldanha et al., 11 where primary outcomes were the most well specified. However, there are objective definitions of healing available; for example, a large RCT of a leg ulcer intervention defined healing of venous leg ulcer as "complete epithelial cover in the absence of a scab (eschar) with no dressing required." 126 The Food and Drug Administration (FDA) defines complete wound closure as "skin reepithelialisation without drainage or dressing requirements, confirmed at two consecutive study visits two weeks apart, and the time should be specified when being analyzed." 124 None of the review protocols we examined used these or similar definitions of wound healing. Secondary outcomes such as pain, quality of life, and cost were generally the least-well specified elements. These are outcomes widely measured using a vast number of approaches, including some approaches that are well-validated and others that are not. Quality of life was also the most poorly specified outcome domain in Cochrane reviews in the field of eyes and vision 11 as well as one of the outcome domains also not well specified in RCTs. (51) 4% (2) 96% (50) Wound infection 66% (21) 34% (11) 50% (16) 3% ( 98% (59) 2% (1) 98% ( 5% (3) 95% (53) Outcomes prespecification in Cochrane wounds systematic reviews Liu et al.
Implication of findings
It is accepted practice that target outcomes for RCTs are fully specified in trial protocols. Systematic reviewers must practise the same when writing systematic review protocols. It has been suggested that outcomes might be poorly prespecified in systematic review protocols because reviewers tend to be responsive to the outcomes that have been reported by trialists and that full outcome specification is a rather novel idea in the systematic review community.
11
There also is a sense that reviewers might be aware of the way outcomes are typically reported in RCTs (indeed they are part of the same community), and might be reluctant to specify outcomes too narrowly a priori with the consequent risk of reducing the volume of data or missing something "important." Our findings, together with these possible explanations, suggest that there is value in developing core outcome sets in the field of wound care, just as there have been in other fields. 14, 16, 17 Our search of the COMET Database on November 21, 2016 revealed the lack of a published core outcome set for research addressing wound care. We believe the wounds research, clinical practice, and patient communities will greatly benefit from having agreed sets of outcomes that are considered important. This would enable an examination and comparison of the effectiveness of different clinical interventions based on a core set of outcomes.
The development of core outcome sets involves a consensus process. The process to define outcome measures should be data-driven, iterative, and prepared by expert working groups, including patients, wound specialists, health professionals, trialists, methodologists, scientists from industry, and regulators. 13 A final consensus should be formulated based on all participants' views and preferences. 13 Our study, by documenting the most frequent outcome domains and their degree of specification, could provide a useful starting point for the development of core outcome sets for wounds research. It is likely that different outcome sets will be needed for different wound types (e.g., those healing by primary vs. those healing by secondary intention). Wound healing as a domain is difficult to apply to surgical wounds healing by primary intention because it is difficult or impossible to define or identify when wound healing occurs; it is more useful and relevant to count problems with wound healing (such as infection or dehiscence).
Finally, development of core outcome sets and full prespecification of outcomes play an important role in reducing bias in systematic reviews. Such approaches help reduce outcome reporting bias by: (1) preventing selection of outcomes for systematic reviews based on the direction or significance of the trial results, and (2) preventing the inclusion of outcomes based on knowledge of those that have been included in RCTs rather than those that are known to be important to decision makers. 13, 15 Authors of future systematic reviews are strongly encouraged to follow this methodological guidance regarding outcome selection, specification, and reporting.
CONCLUSIONS
There is growing recognition that more attention needs to be paid to the outcomes measured in clinical trials and systematic reviews of randomized trials. 11 The usefulness of the studies is compromised by inconsistency in the outcomes assessed across the different studies. The development of core outcome sets is one response to this problem. We strongly recommend that authors of systematic reviews make greater efforts to specify in detail, at the protocol stage, all outcomes of interest using the five elements of a completely specified outcome (domain, specific measurement, specific metric, method of aggregation, and time points). This could go a long way toward reducing bias in data abstraction and analysis in systematic reviews and, ultimately, make a more unbiased summary of the evidence for decision makers. 6 . Topical silver for treating infected wounds 22 7. Antibiotic prophylaxis for preventing burn wound infection 23 8. Dressings for superficial and partial thickness burns 24 9. High-carbohydrate, high-protein, low-fat vs. lowcarbohydrate, high-protein, high-fat enteral feeds for burns 25 10. Honey as a topical treatment for wounds 26 11. Interventions for treating phosphorus burns 27 12. Negative pressure wound therapy for partial-thickness burns 28 13. Recombinant human growth hormone for treating burns and donor sites 29 (Continued) 
ACKNOWLEDGMENTS
